The Impact of Prior Antithrombotic use on Thromboembolic Events in Patients with Cardiovascular Disease and Severe COVID-19 Infection.

Amine BouchlarhemSoumia BoulouizGhizlane El AidouniHoussam BkiyarZakaria BazidNabila IsmailiBrahim HousniNoha El Ouafi

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

Prior use of antithrombotic drugs is a protective factor against thromboembolic complications in patients with a history of heart disease but without effect on mortality.

Keyphrases

atrial fibrillation
cardiovascular disease
cardiovascular events
risk factors
early onset
type diabetes
drug induced
metabolic syndrome